Literature DB >> 18991867

Acute increase of the glutamate-glutamine cycling in discrete brain areas after administration of a single dose of amphetamine.

Frederico C Pereira1, Marta R Rolo, Elsa Marques, Vera M Mendes, Carlos F Ribeiro, Syed F Ali, Teresa Morgadinho, Tice R Macedo.   

Abstract

The glutamate-glutamine cycle between neurons and glia is tightly related to excitatory glutamatergic and inhibitory GABAergic regulation in brain. The role of this neuron-astrocyte cross-talk on the neurotoxicity induced by amphetamines is not understood. Also, the impact of neurotoxic doses of amphetamines on the balance between glutamatergic and GABAergic circuits is largely unknown. The aim of this work was to assess the acute effect of a neurotoxic regimen of amphetamine (AMPH) on glutamine (GLN, an astrocytic marker) levels and on glutamine/glutamate (an index for glutamate-glutamine cycle) and GABA/glutamate ratios in rat brain. Sprague-Dawley rats were sacrificed 4 and 24 h after a single-dose regimen of AMPH (30 mg/kg, i.p.), and the caudate-putamen (CPu), frontal cortex (FC), and hippocampus (Hp) were dissected for analysis of glutamate (GLU), gamma-aminobutyric acid (GABA), and GLN. The total content of these amino acids was measured using a microbore HPLC electrochemical detector. Although AMPH did not change GLU levels, it increased both GLN content and GLN/GLU ratio (160-469%) at 4 h, but not at 24 h, in all regions after injection. Striatal GABA levels and GABA/GLU ratio were increased (46 and 100%, respectively) at 24 h. In hippocampus the GABA/GLU increase (60%) occurred as early as 4 h after treatment. To the contrary, AMPH exerted no effect in GABA/GLU balance in frontal cortex. These data strongly suggest that this neurotoxic AMPH regimen provoked an early increase in the glutamate-glutamine cycle between neurons and glia. This increase may ultimately lead to an upregulation of the inhibitory system as a compensatory response.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18991867     DOI: 10.1196/annals.1432.040

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  10 in total

1.  Acute restraint-mediated increases in glutamate levels in the rat brain: an in vivo ¹H-MRS study at 4.7 T.

Authors:  Sang-Young Kim; Eun-Ju Jang; Kwan Su Hong; Chulhyun Lee; Do-Wan Lee; Chi-Bong Choi; Hyunseung Lee; Bo-Young Choe
Journal:  Neurochem Res       Date:  2011-12-22       Impact factor: 3.996

2.  Brain and cognition abnormalities in long-term anabolic-androgenic steroid users.

Authors:  Marc J Kaufman; Amy C Janes; James I Hudson; Brian P Brennan; Gen Kanayama; Andrew R Kerrigan; J Eric Jensen; Harrison G Pope
Journal:  Drug Alcohol Depend       Date:  2015-05-07       Impact factor: 4.492

Review 3.  Methamphetamine, neurotransmitters and neurodevelopment.

Authors:  B Čechová; R Šlamberová
Journal:  Physiol Res       Date:  2021-12-31       Impact factor: 1.881

4.  Relationship among Glutamine, γ-Aminobutyric Acid, and Social Cognition in Autism Spectrum Disorders.

Authors:  David M Cochran; Elif M Sikoglu; Steven M Hodge; Richard A E Edden; Ann Foley; David N Kennedy; Constance M Moore; Jean A Frazier
Journal:  J Child Adolesc Psychopharmacol       Date:  2015-04-28       Impact factor: 2.576

5.  Neurochemical changes in the rat prefrontal cortex following acute phencyclidine treatment: an in vivo localized (1)H MRS study.

Authors:  Isabelle Iltis; Dee M Koski; Lynn E Eberly; Christopher D Nelson; Dinesh K Deelchand; Julien Valette; Kamil Ugurbil; Kelvin O Lim; Pierre-Gilles Henry
Journal:  NMR Biomed       Date:  2009-08       Impact factor: 4.044

6.  NMR-based metabolomics characterizes metabolic changes in different brain regions of streptozotocin-induced diabetic mice with cognitive decline.

Authors:  Tingting Zhang; Hong Zheng; Kai Fan; Nengzhi Xia; Jiance Li; Changwei Yang; Hongchang Gao; Yunjun Yang
Journal:  Metab Brain Dis       Date:  2020-07-08       Impact factor: 3.584

Review 7.  The role of the GABA system in amphetamine-type stimulant use disorders.

Authors:  Dongliang Jiao; Yao Liu; Xiaohong Li; Jinggen Liu; Min Zhao
Journal:  Front Cell Neurosci       Date:  2015-05-05       Impact factor: 5.505

8.  Enhanced Dopamine in Prodromal Schizophrenia (EDiPS): a new animal model of relevance to schizophrenia.

Authors:  Alice Petty; Xiaoying Cui; Yasvir Tesiram; Deniz Kirik; Oliver Howes; Darryl Eyles
Journal:  NPJ Schizophr       Date:  2019-03-29

9.  In Silico Prediction of Gamma-Aminobutyric Acid Type-A Receptors Using Novel Machine-Learning-Based SVM and GBDT Approaches.

Authors:  Zhijun Liao; Yong Huang; Xiaodong Yue; Huijuan Lu; Ping Xuan; Ying Ju
Journal:  Biomed Res Int       Date:  2016-08-08       Impact factor: 3.411

10.  Quantification of GABA, glutamate and glutamine in a single measurement at 3 T using GABA-edited MEGA-PRESS.

Authors:  Faezeh Sanaei Nezhad; Adriana Anton; Emilia Michou; JeYoung Jung; Laura M Parkes; Stephen R Williams
Journal:  NMR Biomed       Date:  2017-11-12       Impact factor: 4.044

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.